tricalcium phosphate has been researched along with foscarnet in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sallis, JD; Williams, G | 1 |
Loghman-Adham, M | 1 |
Sorribas, V; Villa-Bellosta, R | 1 |
Fullerton, DA; Lee, JH; Meng, X; Nadlonek, NA; Weyant, MJ | 1 |
1 review(s) available for tricalcium phosphate and foscarnet
Article | Year |
---|---|
Use of phosphonocarboxylic acids as inhibitors of sodium-phosphate cotransport.
Topics: Animals; Antiviral Agents; Biological Transport; Calcium Phosphates; Carrier Proteins; Digestive System; Foscarnet; Intestinal Absorption; Kidney; Phosphates; Sodium-Phosphate Cotransporter Proteins; Symporters | 1996 |
3 other study(ies) available for tricalcium phosphate and foscarnet
Article | Year |
---|---|
Structural factors influencing the ability of compounds to inhibit hydroxyapatite formation.
Topics: Adenosine Triphosphate; Calcium Phosphates; Citrates; Citric Acid; Durapatite; Etidronic Acid; Foscarnet; Glyceric Acids; Hydroxyapatites; Lasers; Magnesium; Nephelometry and Turbidimetry; Phosphates; Phosphonoacetic Acid; Structure-Activity Relationship | 1982 |
Phosphonoformic acid prevents vascular smooth muscle cell calcification by inhibiting calcium-phosphate deposition.
Topics: Animals; Calcinosis; Calcium Phosphates; Cells, Cultured; Foscarnet; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphate Transport Proteins; Rats; Reverse Transcriptase Inhibitors | 2009 |
ox-LDL induces PiT-1 expression in human aortic valve interstitial cells.
Topics: Adult; Aortic Valve; Aortic Valve Stenosis; Bone Morphogenetic Protein 2; Calcinosis; Calcium Phosphates; Cells, Cultured; Foscarnet; Humans; Lipoproteins, LDL; Male; Middle Aged; Prevalence; Risk Factors; Signal Transduction; Sodium-Phosphate Cotransporter Proteins, Type III | 2013 |